Lavina Talukdar, CFASr. Vice President - Head, Investor RelationsModernaMs. Talukdar joined Moderna as Head, Investor Relations in April 2019 after a 20 year career as a biotech and healthcare investor.
Lavina Talukdar, CFASr. Vice President - Head, Investor RelationsModernaMs. Talukdar joined Moderna as Head, Investor Relations in April 2019 after a 20 year career as a biotech and healthcare investor. Most recently, she was a Senior Portfolio Manager at Abu Dhabi Investment Authority (ADIA) where she led healthcare investments and led ADIA’s investment in MRNA. Prior to ADIA, she was a Partner and Senior Research Analyst for Lord Abbett & Co., Senior Analyst at MFS and Principal at State Street Global Advisors. She started her career in the late 1990’s covering biotech for Fiduciary Trust.
